UK-based OXIS Energy has announced several significant companies want to fund the latest lithium sulfur battery technology, the company said.
OXIS Energy is leading the world in the development of Li-S chemistry that can be used in many battery applications.
Safran is an international high-technology group, operating in the aircraft propulsion and equipment, space and defence markets. It is number one in the world for single-aisle commercial jet engines. Aside from its latest contribution, it has hitherto signed a Joint Development Agreement with OXIS to develop battery systems for commercial aircraft.
The Aerotec Brazil investment makes it the second largest shareholder in OXIS Energy after Sasol, South Africa. Aerotec is a multi-million-pound fund managed by Confrapar, a leading private equity fund manager focused on technology companies in Latin America.
Arkema is a global chemical company. A leader in speciality chemicals and advanced materials, its collaboration with OXIS has had a major impact on the improvement in energy densities and the composition of the chemicals used in the making of OXIS Li-S cell technology. This is due to the large range of innovative solutions it has in its portfolio such as carbon nanotubes, electrolyte and advanced technical polymers. In 2017, Arkema had a turnover of EUR 8.3bn and has been in collaboration with OXIS since 2012.
The investments made by these companies take the total capital raised to just under GBP 24m and include Samsung Ventures which contributed to the fund in December 2016 and is a shareholder in OXIS Energy. The capital raised will be used to commercialise and automate the process of mass production of rechargeable Lithium Sulfur cells/modules, using state of the art digital manufacturing machinery, deployed by expert skills of companies such as Nordika and Siemens AG for worldwide distribution to manufacturers of vehicles.
OXIS intends to focus on the aviation, defence and the heavy electric vehicles markets, such as buses and trucks.
OXIS Energy Ltd is involved in the design, development and now the move towards commercial production of Lithium Sulfur cells for battery systems. With 39 patent families, OXIS has been granted 173 patents with 96 pending.